← All Actinium Pharmaceuticals, INC filings

Actinium Pharmaceuticals, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

AMEX
ATNM
Actinium Pharmaceuticals, INC
SCHEDULE: Vanguard Group Discloses 4.39% Stake in Actinium Pharmaceuticals
The Vanguard Group has reported a 4.39% beneficial ownership stake in Actinium Pharmaceuticals Inc., holding 1,371,840 shares of common stock.
AMEX
ATNM
Actinium Pharmaceuticals, INC
SCHEDULE 13G/A: BlackRock Discloses 1.5% Passive Stake in Actinium Pharmaceuticals
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 1.5% passive beneficial ownership stake in Actinium Pharmaceuticals, Inc. as of June 30, 2025.